Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siow Ming Lee

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cancer Medicine|August 10, 2013
A potential new enriching trial design for selecting non-small-cell lung cancer patients with no predictive biomarker for trials based on both histology and early tumor response: further analysis of a thalidomide trialSiow Ming Lee, Allan Hackshaw
Translational Lung Cancer Research|May 18, 2016
Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastasesDanny Ulahannan, Siow-Ming Lee
Expert Opinion on Investigational Drugs|March 5, 2013
Axitinib for the treatment of advanced non-small-cell lung cancerJudy W King, Siow-Ming Lee
Expert Opinion on Biological Therapy|November 21, 2009
Glucarpidase following high-dose methotrexate: update on developmentDaniel M Patterson, Siow Ming Lee
Respirology (Carlton, Vic.)|March 27, 2010
Anti-angiogenesis drugs in lung cancerSiow Ming Lee, Paul Baas, Heather Wakelee
BMJ Open|July 4, 2015
Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapyIftekhar Khan, Stephen Morris, Allan Hackshaw, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancerSiow Ming Lee, Lindsay James, Tomas Buchler, et al.
Clinical Nuclear Medicine|June 14, 2012
The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CTSatveer K Mankia, Robert F Miller, Simon G Edwards, et al.
JTO Clinical and Research Reports|November 25, 2024
Entrectinib-Induced Myocarditis and Acute Heart Failure Responding to Steroid Treatment: A Case ReportMehraab N Majeed, Subramanian Venkatesan, Dionysis Papadatos-Pastos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancerSiow Ming Lee, Robin Rudd, Penella J Woll, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cancer Medicine|August 10, 2013
A potential new enriching trial design for selecting non-small-cell lung cancer patients with no predictive biomarker for trials based on both histology and early tumor response: further analysis of a thalidomide trialSiow Ming Lee, Allan Hackshaw
Translational Lung Cancer Research|May 18, 2016
Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastasesDanny Ulahannan, Siow-Ming Lee
Expert Opinion on Investigational Drugs|March 5, 2013
Axitinib for the treatment of advanced non-small-cell lung cancerJudy W King, Siow-Ming Lee
Expert Opinion on Biological Therapy|November 21, 2009
Glucarpidase following high-dose methotrexate: update on developmentDaniel M Patterson, Siow Ming Lee
Respirology (Carlton, Vic.)|March 27, 2010
Anti-angiogenesis drugs in lung cancerSiow Ming Lee, Paul Baas, Heather Wakelee
BMJ Open|July 4, 2015
Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapyIftekhar Khan, Stephen Morris, Allan Hackshaw, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancerSiow Ming Lee, Lindsay James, Tomas Buchler, et al.
Clinical Nuclear Medicine|June 14, 2012
The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CTSatveer K Mankia, Robert F Miller, Simon G Edwards, et al.
JTO Clinical and Research Reports|November 25, 2024
Entrectinib-Induced Myocarditis and Acute Heart Failure Responding to Steroid Treatment: A Case ReportMehraab N Majeed, Subramanian Venkatesan, Dionysis Papadatos-Pastos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancerSiow Ming Lee, Robin Rudd, Penella J Woll, et al.
Pageof 5